pubmed-article:19550295 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19550295 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
pubmed-article:19550295 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
pubmed-article:19550295 | lifeskim:mentions | umls-concept:C0010868 | lld:lifeskim |
pubmed-article:19550295 | lifeskim:mentions | umls-concept:C0040845 | lld:lifeskim |
pubmed-article:19550295 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:19550295 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19550295 | pubmed:dateCreated | 2009-12-23 | lld:pubmed |
pubmed-article:19550295 | pubmed:abstractText | Neuroblastoma is an important pediatric tumor in which Myc-N amplification is a well-known poor prognostic indicator. It has a great diversity in clinical behavior. The effect of pharmacologic agents used in neuroblastoma treatment on Myc-N expression is still unclear. | lld:pubmed |
pubmed-article:19550295 | pubmed:language | eng | lld:pubmed |
pubmed-article:19550295 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19550295 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19550295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19550295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19550295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19550295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19550295 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19550295 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19550295 | pubmed:issn | 1533-4058 | lld:pubmed |
pubmed-article:19550295 | pubmed:author | pubmed-author:OlgunNurN | lld:pubmed |
pubmed-article:19550295 | pubmed:author | pubmed-author:AktasSafiyeS | lld:pubmed |
pubmed-article:19550295 | pubmed:author | pubmed-author:ErbayraktarZu... | lld:pubmed |
pubmed-article:19550295 | pubmed:author | pubmed-author:AltunZekiyeZ | lld:pubmed |
pubmed-article:19550295 | pubmed:author | pubmed-author:AygunNevimN | lld:pubmed |
pubmed-article:19550295 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19550295 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:19550295 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19550295 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19550295 | pubmed:pagination | 86-9 | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:meshHeading | pubmed-meshheading:19550295... | lld:pubmed |
pubmed-article:19550295 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:19550295 | pubmed:articleTitle | Effect of cytotoxic agents and retinoic acid on Myc-N protein expression in neuroblastoma. | lld:pubmed |
pubmed-article:19550295 | pubmed:affiliation | Institute of Oncology, Dokuz Eylul University, Izmir, Turkey. safiyeaktas@yahoo.com | lld:pubmed |
pubmed-article:19550295 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19550295 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |